Sign Up to like & get
recommendations!
1
Published in 2022 at "Current pharmaceutical biotechnology"
DOI: 10.2174/1389201023666220922122531
Abstract: BACKGROUND Nanocarriers are these days considered an attractive approach in cancer immunotherapy owing to their ability to deliver antigens to antigen-presenting cells (APCs) for stimulating robust immune cells against the tumor. OBJECTIVES The objective of…
read more here.
Keywords:
mhc specific;
heterologous prime;
prime boost;
albumin ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.586856
Abstract: Humoral immunity is a major barrier limiting long-term outcome after organ transplantation. Especially, the production of antibodies directed against donor HLA/MHC antigens (i.e. donor-specific antibodies (DSA)) leading to antibody-mediated rejection (ABMR) is considered to be…
read more here.
Keywords:
detection;
mhc specific;
specific ige;
mice ... See more keywords